KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Lam Research (LRCX) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.

  • Lam Research's Accounts Payables rose 2488.93% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 2488.93%. This contributed to the annual value of $854.2 million for FY2025, which is 3912.95% up from last year.
  • Latest data reveals that Lam Research reported Accounts Payables of $1.0 billion as of Q4 2025, which was up 2488.93% from $863.2 million recorded in Q3 2025.
  • In the past 5 years, Lam Research's Accounts Payables ranged from a high of $1.1 billion in Q3 2022 and a low of $470.7 million during Q2 2023
  • Its 5-year average for Accounts Payables is $791.8 million, with a median of $833.7 million in 2021.
  • In the last 5 years, Lam Research's Accounts Payables tumbled by 5392.4% in 2023 and then soared by 6455.3% in 2024.
  • Over the past 5 years, Lam Research's Accounts Payables (Quarter) stood at $952.7 million in 2021, then decreased by 3.49% to $919.4 million in 2022, then plummeted by 45.65% to $499.7 million in 2023, then surged by 64.55% to $822.3 million in 2024, then rose by 24.89% to $1.0 billion in 2025.
  • Its Accounts Payables was $1.0 billion in Q4 2025, compared to $863.2 million in Q3 2025 and $854.2 million in Q2 2025.